Avoro Capital Advisors LLC 13D/13G Filings for Acceleron Pharma Inc. (XLRN)

Avoro Capital Advisors LLC 13D and 13G filings for Acceleron Pharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-11-24
3:48 pm
Sale		2021-11-2213DAcceleron Pharma Inc.
XLRN		Avoro Capital Advisors LLC0
0.000%		-4,476,100decrease
(Position Closed)		Filing
2021-10-05
12:30 pm
Purchase		2021-09-3013DAcceleron Pharma Inc.
XLRN		Avoro Capital Advisors LLC4,476,100
7.300%		4,476,100increase
(New Position)		Filing